Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04404140
Title A Study Evaluating The Safety, Efficacy and Pharmacokinetics Of Ipatasertib In Combination With Atezolizumab And Docetaxel In Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche

prostate adenocarcinoma


Atezolizumab + Docetaxel + Ipatasertib

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP

No variant requirements are available.